Latest 8-K filings

HubSpot reaffirms financial guidance while announcing a strategic restructuring involving the elimination of approximately 7% of its workforce, impacting around 660 employees.

MAIA Biotechnology, Inc. has filed a Form 8-K to disclose presentation materials and a summary highlighting operations and performance, emphasizing forward-looking statements.

Stryker Corporation has announced a planned leadership succession, with current CEO Kevin Lobo transitioning to Executive Chair and Spencer Stiles appointed as the new CEO, effective January 1, 2027.

International Bancshares Corporation announced its intention to transfer its primary stock listing from Nasdaq to the Texas Stock Exchange, effective October 19, 2026.

ArriVent BioPharma announced its Phase 3 FURVENT trial for firmonertinib in NSCLC did not meet its primary endpoint of progression-free survival.

PDS Biotechnology Corporation announced a virtual Key Opinion Leader event on October 15, 2026, to discuss clinical outcomes of PDS0301 for advanced liver-associated cancers, focusing on metastatic colorectal cancer.

Netlist, Inc. has entered into a comprehensive settlement and patent license agreement with Micron Technology, Inc., resolving all legal disputes and securing $600 million in quarterly payments over five years.

McKesson Corporation and Clayton, Dubilier & Rice will acquire Option Care Health for approximately $5.8 billion, with McKesson taking a minority stake.

Lamb Weston Holdings, Inc. reported first quarter fiscal 2027 results above expectations, leading to an increased full-year financial outlook.

H.B. Fuller Company announced a $950 million senior unsecured notes offering to finance its acquisition of Advanced Medical Solutions Group plc, with provisions for redemption if the acquisition does not close.

Portillo's Inc. announced the departure of its Chief People Officer, Jill Waite, effective November 1, 2026, with a separation agreement outlining severance benefits and equity vesting.

B&G Foods and Nortera Foods have mutually terminated their agreement for the sale of Green Giant Canada due to a failure to obtain regulatory approval by the specified deadline.

1606 Corp. reports significant interest and site visits for its East Texas energy and data center project, with multiple parties evaluating various transaction structures.

Telomir Pharmaceuticals announced a $5.6 million PIPE financing, including an investment from John Paul DeJoria, to fund its lead drug candidate's clinical development.

Boost Run Inc. announced a substantial five-year service agreement with Cohere Inc. for dedicated GPU cloud computing infrastructure, committing Cohere to approximately $525.6 million in payments.

SideChannel, Inc. has filed a certificate of amendment to significantly decrease its authorized common and preferred stock.

Entera Bio Ltd. announced the appointment of seasoned biopharmaceutical executive Laura Hamill to its Board of Directors, effective December 1, 2026, to enhance commercial expertise.

OFS Capital Corporation's subsidiary, OFS SBIC I, LP, has admitted a new third-party investor, acquiring a majority stake in the subsidiary's limited partnership interests.

Evolution Metals & Technologies Corp. has entered into a Letter of Intent with INERGX Energy Optimisation Ltd. to provide energy storage and power optimization systems for its planned U.S. critical materials and battery black mass recovery facility.

Regeneron Pharmaceuticals and Sanofi have entered into a significant amendment to their collaboration agreement, involving co-development and co-commercialization of four new antibody assets and a $1 billion upfront payment.

60 Degrees Pharmaceuticals announced an update on its severe babesiosis study, concluding enrollment and planning a data readout in January 2027, alongside a pre-sNDA meeting with the FDA.

Valion Bio announces Thomas H. Jensen as new Board Chair, bringing extensive biotech turnaround experience to advance Entolimod's development for acute radiation syndrome.

Kairos Pharma announced statistically significant interim efficacy data from its Phase 2 trial of ENV-105 in metastatic prostate cancer, leading to protocol modifications.

Professional Diversity Network, Inc. announces a significant step in its AI infrastructure strategy with an order for an NVIDIA B300-based AI computing system through its subsidiary, PDN Intelligence.

Indivior Pharmaceuticals, Inc. has filed a supplement to its merger proxy statement/prospectus to address disclosure claims raised by Supernus Pharmaceuticals stockholders, while reaffirming the terms of the proposed merger.

Beeline Holdings anticipates its strongest Q3 revenue since 2021, record margins, and a reduced net loss, alongside the launch of a Home Equity Investment product.

Digital Realty Trust, Inc. announced the commencement of an offering for Euro-denominated Guaranteed Notes and the pricing of Swiss Franc Notes, with proceeds intended for green projects and general corporate purposes.

RPM International Inc. announced record-breaking first-quarter results for fiscal year 2027, with sales reaching $2.22 billion and diluted EPS at $2.01.

Barnwell Industries has agreed to sell its Canadian oil and natural gas business for C$9 million, comprising C$4 million in cash and a 5% gross overriding royalty.

HighPeak Energy announced a $450 million preferred equity investment and an $800 million credit facility to refinance its existing term loan, significantly improving its financial flexibility.